CRISPR Therapeutics raised €23M in a Series A round in Apr 2014. The company is based in Basel, Switzerland. Investors in the round: Versant Ventures. Data as of 7 Aug 2026.
Reported in EUR — no conversion. €23M
No source on record — unverified.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
